









Markets
/
Stocks
/
nasdaq-vtak
/

Catheter Precision Inc

VTAK

2.400USD

-0.250-9.29%

Close 09/19, 16:00（ET）Quotes delayed by 15 min

2.38MMarket Cap

LossP/E TTM



Catheter Precision Inc

2.400

-0.250-9.29%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively stable. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a . Despite a good stock market performance, the company shows weak fundamentals and technicals, which don't support the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

152 / 207

Overall Ranking

506 / 4720

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 0 analysts

Current Rating

38.000

Target Price

+1312.64%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Catheter Precision, Inc. is a medical device company. It is engaged in providing new solutions to the market to improve the treatment of cardiac arrhythmias. It is focused on developing technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products. It is also focused on developing and delivering electrophysiology products to provide patients, hospitals, and physicians with novel technologies and solutions to improve the lives of patients with cardiac arrhythmias. Its product is the VIVO System, which is an anacronym for View into Ventricular Onset System, which is a non-invasive imaging system that offers three-dimensional cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients. Its LockeT product is a suture retention device indicated for wound healing. Its product portfolio also includes the Amigo Remote Catheter System, a robotic arm that serves as a catheter control device.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 2900.00% year-on-year.

Growing

The company is in a growing phase, with the latest annual income totaling USD 420.00K.

Fairly Valued

The company’s latest PE is -0.02, at a medium 3-year percentile range.

Institutional Buying

The latest institutional holdings are 1.62M shares, increasing 12.19% quarter-over-quarter.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.33.

Financial Health

Currency: USD Updated: 2025-09-19

The company's current financial score is 5.43, which is lower than the Healthcare Equipment & Supplies industry's average of 7.32. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 212.00K, representing a year-over-year increase of 127.96%, while its net profit experienced a year-over-year increase of 21.07%.

Score

Industry at a Glance

Previous score

5.43

Change



Financials

4.10

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

6.84

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

2.77

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

6.35

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.09

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated: 2025-09-19

The company’s current valuation score is 2.80, which is lower than the Healthcare Equipment & Supplies industry's average of 3.59. Its current P/E ratio is -0.02, which is -74.51% below the recent high of -0.01 and -131.86% above the recent low of -0.05.

Score

Industry at a Glance

Previous score

2.80

Change

1.2

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 152/207

No Data

Earnings Forecast

Currency: USD Updated: 2025-09-19

There is no earnings forecast score for this company; the Healthcare Equipment & Supplies industry's average is 7.70. The average price target for Catheter Precision Inc is 38.00, with a high of 38.00 and a low of 38.00.

Score

Industry at a Glance

Previous score

0.00

Change

Support & Resistance

No Data

No Data

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-19

The company’s current price momentum score is 2.43, which is lower than the Healthcare Equipment & Supplies industry's average of 6.80. Sideways: Currently, the stock price is trading between the resistance level at 3.09 and the support level at 2.32, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

2.43

Change

-0.15

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(3)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.168

Neutral

RSI(14)

54.895

Neutral

STOCH(KDJ)(9,3,3)

42.785

Sell

ATR(14)

0.151

High Vlolatility

CCI(14)

-40.345

Neutral

Williams %R

90.244

Oversold

TRIX(12,20)

1.911

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

2.562

Sell

MA10

2.512

Sell

MA20

2.571

Sell

MA50

1.448

Buy

MA100

0.858

Buy

MA200

0.617

Buy

Institutional Confidence

Currency: USD Updated: 2025-09-19

Score

Industry at a Glance

Previous score

3.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

Jenkins Family Charitable Institute

700.23K

+39.98%

Jenkins (David A)

194.18K

Citadel Advisors LLC

32.97K

UBS Financial Services, Inc.

1.00K

+646.27%

FatBoy Capital LP

70.97K

Geode Capital Management, L.L.C.

54.21K

+619.01%

Caruso (James Joseph)

34.76K

+0.60%

Risk Assessment

Currency: USD Updated: 2025-09-19

The company’s current risk assessment score is 3.00, which is lower than the Healthcare Equipment & Supplies industry's average of 3.87. The company's beta value is -0.82. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.